Saturday, December 21, 2024

TetraScience Unveils Universal Chromatography Dashboard

Related stories

Doc.com Expands AI developments to Revolutionize Healthcare Access

Doc.com, a pioneering healthcare technology company, proudly announces the development...

Amesite Announces AI-Powered NurseMagic™ Growth in Marketing Reach to Key Markets

Amesite Inc., creator of the AI-powered NurseMagic™ app, announces...

Quantiphi Joins AWS Generative AI Partner Innovation Alliance

Quantiphi, an AI-first digital engineering company, has been named...
spot_imgspot_img

TetraScience, the Scientific Data and AI Cloud, announced the launch of Chromatography Insights, the biopharmaceutical industry’s first and only universal chromatography dashboard that seamlessly integrates data from any vendor’s Chromatography Data System (CDS).

Chromatography data represents more than 50% of analytical data in therapeutic development and production. Yet, labs struggle with fragmented data, leading to delays and potential compliance risks. Chromatography Insights addresses these challenges by automating data collection and harmonization and consolidating key metrics such as method, column, and instrument performance into a single interactive dashboard.

Chromatography Insights enables a comprehensive view across departments, locations, and projects with minutes-level latency at an enterprise scale of over 10 million injections. This enterprise-grade, vendor-agnostic solution allows scientists, quality staff, lab leaders, and cross-functional groups to make smarter, faster decisions for enhanced process control, safer batch release, and stability studies. Only with TetraScience’s vendor-neutral approach can life sciences organizations contextualize their CDS data with information from data sources such as electronic lab notebooks (ELNs), laboratory information management systems (LIMSs), and enterprise resource planning (ERP) systems.

Chromatography Insights showcases the value of the Tetra Scientific Data and AI CloudTM, which re-platforms and engineers raw and siloed scientific data into more-than-FAIR datasets that come to life in a growing suite of next-generation data apps, analytics, and scientific AI use cases.

Also Read: TetraScience Collaborates With NVIDIA

“Siloed chromatography data hampers pharmaceutical organizations from making rapid, informed decisions about their development and manufacturing processes,” said Patrick Grady, CEO of TetraScience. “With Chromatography Insights, we’re transforming how the industry manages and uses this critical data, enabling organizations to reduce out-of-spec results by over 75% through proactive monitoring while building the foundation for AI-driven decision-making.”

With Chromatography Insights, scientific and analytics teams can:

  • Automate data collection and analysis across multiple sources, transitioning scientists from manual data handling to value-added work.
  • Accelerate method development and tech transfer with complete visibility across CDSs, projects, and sites – troubleshoot faster, make informed decisions, and build future-ready methods with predictive AI.
  • Transform quality by unifying batch performance data across all systems, enabling early detection of trends before they lead to time-consuming out-of-spec investigations, delayed batch release, or costly recalls.
  • Gain centralized, comprehensive data access to surface critical compliance points – like injection counts and adherence to standard operating procedures – streamlining audits and minimizing risk. Reduce manual checks, build data confidence, and ensure proactive compliance with near real-time insights.
  • Harmonize chromatography results into AI-ready datasets across all CDS platforms, accelerating your path to predictive modeling.

Early adopters have reported significant improvements in operational efficiency and quality control. Organizations using Chromatography Insights have successfully:

  • Reduced investigation time for out-of-spec results by up to 75%
  • Decreased method transfer time between sites by 50%
  • Significantly improved compliance monitoring through automated tracking of injection counts and SOP adherence

Source: Businesswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img